Epocrates - Crunchbase Company Profile & Funding

Q: Who invested in Epocrates?

Epocrates has 5 investors including Goldman Sachs And Sprout Group.

Q: When was the last funding round for Epocrates?

Epocrates closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Epocrates raised to date?

Epocrates has raised obfuscated.

Overview

Epocrates

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Epocrates

CB Rank

267736

Epocrates develops software that provides reference information about drugs and diseases, and diagnostic tools for healthcare professionals.

Acquired by

Athenahealth

Founded

obfuscation

Delisted

Venture - Series Unknown

San Mateo, California, United States

1001-5000

www.epocrates.com

Health Care

Mobile

Software

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Dave Ward: Executive Vice President
Past Role: IBM, Sales and Marketing Positions

Details

Sub-Organization of

Athenahealth

Legal Name

Epocrates, LLC

Operating Status

Active

Stock Symbol

NASDAQ:EPOC

Company Type

For Profit

Founders

Richard Fiedotin, Tom X Lee

About the Company

Epocrates develops mobile and online clinical information and decision support software that enables health-care professionals to find answers more quickly and confidently at the point of care. 1 out of 3 U.S. physicians and 1 out of 3 U.S. medical students currently use Epocrates software.

Phone Number

800.230.2150

Related Hubs

Epocrates Alumni Founded Companies

Diversity Spotlight

Women Led

Predictions & Insights

Products & Services

Epocrates Mobile Medical Reference App

A mobile application providing clinicians with up-to-date drug, disease, and diagnostic reference information to support clinical decision-making.

Bugs + Drugs Antimicrobial Susceptibility Tool

A mobile tool providing geolocated data on bacterial types and resistance patterns to guide antimicrobial prescribing decisions.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Epocrates	1	obfuscated obfuscation	Goldman Sachs	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Goldman Sachs	Yes	Venture Round - Epocrates	—
Goldman Sachs	Yes	Venture Round - Epocrates	—
Goldman Sachs	Yes	Venture Round - Epocrates	—
Goldman Sachs	Yes	Venture Round - Epocrates	—
Goldman Sachs	Yes	Venture Round - Epocrates	—